ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Rosetta Genomics Ltd (CE)

Rosetta Genomics Ltd (CE) (ROSGQ)

0,0001
0,00
(0,00%)
Fermé 03 Décembre 10:00PM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
0,0001
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,000001 Plage de 52 semaines 0,0001
Clôture Veille
0,0001
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
60
Volume financier
-
VWAP
-

ROSGQ Dernières nouvelles

Rosetta Genomics Fortifies Patent Protection for its Unique RosettaGX RevealTM Assay

Allowance for U.S. Patent that Covers the Company’s differentiated assay for the diagnosis of thyroid cancer Rosetta Genomics Ltd. (NASDAQ:ROSG), a genomic diagnostics company that...

Rosetta Genomics Announces 1-for-12 Reverse Stock Split

Ordinary Shares Will Begin Trading on a Split-Adjusted Basis on March 17, 2017 Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by...

Rosetta Genomics Closes Second Tranche of Previously Announced Private Placement of Convertible Debentures

Rosetta Genomics Ltd. (NASDAQ:ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and accurate diagnostic information to physicians, announces the...

Rosetta Genomics Reports Preliminary RosettaGX Reveal™ Financial Results for the 2016 Fourth Quarter and Year

Reiterates 2017 RosettaGX Reveal revenue guidance of between $4 million and $5 million as Company increases focus on the Reveal market opportunity Rosetta Genomics Ltd. (NASDAQ:ROSG), a...

Rosetta Genomics Announces Key U.S. Patent Allowances for Two RosettaGx RevealTM microRNAs

Strengthens the Intellectual Property Surrounding the Company’s Novel Thyroid Nodule Classifier and Provides Opportunities for IP Monetization Rosetta Genomics Ltd. (NASDAQ:ROSG), a genomic...

Rosetta Genomics Announces Pricing of $5 Million Concurrent Registered Direct and Private Placement Offering

Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based and other molecular diagnostic testing services, today announced it has entered into definitive...

Rosetta Genomics Enters Research Collaboration using microRNA Biomarkers to Predict Response to Leading Immuno-Oncology Drug ...

Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based and other molecular diagnostics, announces that the Company has entered into a research agreement with...

Clinical Validation Study for RosettaGX Reveal Published in the Journal of Clinical Pathology

Second peer-reviewed publication represents a major milestone that is expected to support continued RosettaGX Reveal momentum Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and...

RosettaGX Reveal™ Analytical Validation Study Featured on the Cover of the October Issue of Cancer Cytopathology

Previously available online, print article enhances awareness of the first commercial test validated to analyze the same thyroid cells on which the initial indeterminate diagnosis was based...

Rosetta Genomics Appoints Mark R. Willig as Chief Commercial Officer

Brings extensive molecular diagnostic commercial and market access leadership to drive revenue and expand reimbursement across portfolio of high-value assays Company expects to build on...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
129.9E-599001.0E-60.00011.0E-6600.0001CS
26000.00010.00011.0E-6484.239E-5CS
52000.00010.00011.0E-611289.817E-5CS
156000.00010.00111.0E-646470.0002539CS
260-0.0067-98.52941176470.00680.391.0E-6229630.07237469CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
KBNTKubient Inc (CE)
US$ 0,0003
(29 900,00%)
400
YAYOYayYo Inc (CE)
US$ 0,0002
(19 900,00%)
15,71k
NHIQNantHealth Inc (CE)
US$ 0,25
(12 400,00%)
1,12k
ARDSAridis Pharmaceuticals Inc (CE)
US$ 0,0001
(9 900,00%)
33,37k
NSTBNorthern Star Investment Corporation II (CE)
US$ 0,01
(9 900,00%)
300
CLVRClever Leaves Holdings Inc (CE)
US$ 0,0002
(-99,98%)
676
CITLFCritical Infrastructure Technologies Ltd (PK)
US$ 0,0001
(-99,96%)
500
RQHTFReliq Health Technologies Inc (CE)
US$ 0,000001
(-99,91%)
100
EORBFOrbite Technologies Inc (CE)
US$ 0,000001
(-99,69%)
95,8k
ANTHAnthera Pharmaceuticals Inc (CE)
US$ 0,000001
(-99,50%)
428
RDARRaadr Inc (PK)
US$ 0,0011
(29,41%)
407,34M
CMGRClubhouse Media Group Inc (PK)
US$ 0,0001
(0,00%)
304,71M
DPUIDiscount Print USA Inc (PK)
US$ 0,0003
(50,00%)
187,09M
HMBLHUMBL Inc (PK)
US$ 0,0003
(50,00%)
105,08M
DRNGDrone Guarder Inc (PK)
US$ 0,00025
(25,00%)
88,96M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock